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a b s t r a c t
Introduction: Burn is among the most severe forms of critical illness, associated with extensive
and prolonged physical, metabolic and mental disorders. The aim of this study was to assess
the effect of an oral, low-cost, and accessible collagen-based supplement on wound healing
in patients with burn.
Methods: In this randomized double-blind controlled pilot clinical trial, 31 men, 1860years,
with 2030% total body surface area burn were studied. Patients were randomly assigned to
receive either a collagen-based supplement (1000kcal) or an isocaloric placebo, for 4 weeks.
Serum pre-albumin, rate of wound healing, length of hospital stay, and anthropometries
were assessed at baseline, and the end of week 2 and 4.
Results: Serum pre-albumin was significantly higher at week 2 (29.713.6 vs. 17.87.5mg/dL,
P=0.006) and week 4 (35.17.6 vs. 28.38.2mg/dL, P=0.023) in collagen than control group.
Changes in pre-albumin concentration were also significantly higher in collagengroup at week
2 (13.99.8 vs. 1.910.3mg/dL, P<0.001) and week 4 (19.27.5 vs. 8.510.1mg/dL, P=0.002).
TheHazard ratioof wound healing was 3.7times in collagen compared tocontrolgroup (95% CI:
1.4349.519, P=0.007). Hospital stay was clinically, but not statistically, lower in collagen than
control group (9.44.6 vs. 13.57 days, P=0.063). There were no significant differences in
weight, body mass index, dietary energy and protein intakes between the two groups.
Conclusion: The findings showed that a hydrolyzed collagen-based supplement could
significantly improve wound healing and circulating pre-albumin, and clinically reduce
hospital stay in patients with 2030% burn.
© 2019 Elsevier Ltd and ISBI. All rights reserved.
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1. Introduction
Burns are among the major traumatic events that usually
require intensive care, and long hospitalization and rehabili-
tation. Based on WHO reports, around 180,000 annual deaths
are attributed to burns, with a considerable fraction in low and
middle-income countries. In addition, in 2004, around 11
million people required medical care due to major burns and
consequent morbidities [1]. The extensive tissue injury in burn
could lead to serious wounds, pain, depressed immunity,
infections, hypermetabolism, muscle wasting, and scars,
which in turn could cause major physical and mental
distresses [2,3]. Accelerating the rehabilitation phase and
wound healing are of importance due to extensive physiologi-
cal, psychological and social consequences of burn. Currently,
wound dressings, different systemic and topical medications,
wound excision and skin grafting, biological and synthetic skin
substitutes, skin tissue engineering and surgical approaches
are available in burn management [2]. Although recent
advancements have substantially improved burn outcomes,
there are still many challenges about their efficacy and
these strategies are relatively costly and not attainable in all
countries.
Nutritional support and dietary supplements are
among the most essential interventions to comply the
metabolic demands and alleviate persistent and profound
hypermetabolism in burn [4]. Data from an international
nutrition survey showed substantial energy and protein
deficit in burn victims receiving enteral nutrition, which
was dose-dependently associated with higher mortality,
irrespective of disease severity [5]. Failure to supply
sufficient energy and nutrients, especially protein, could
interfere with wound healing and delay recovery [6].
Higher protein requirement is the result of urinary and
wound protein losses, increased gluconeogenesis and
tissue repair [7].
Collagen is the main structural component of bones,
muscles, connective tissues and skin. Hydrolyzed collagen
or gelatin is derived from partial hydrolysis of collagen [8].
Previous studies have confirmed the efficacy of hydrolyzed
collagen on wound repair and improvement of skin and
connective tissues [8]. It has been shown that an oral
collagen supplement could improve the healing of pressure
ulcers in residents of long-term-care facilities [9]. Experi-
mental studies have reported the effect of oral collagen
supplements on accelerating the healing of diabetic
wounds [10], alleviating UV induced skin photo-aging
[11], and reducing aging-related changes of the extracellu-
lar matrix [12]. A systematic review of studies in patients
with diabetic foot ulcers showed the efficacy of collagen-
based dressings on wound healing [13]. Collagen-based
biological dressings are also widely applied for the man-
agement of burn wounds [14].
Most of previous studies investigating the effects of
collagen were performed in experimental models or as topical
treatments in clinical conditions other than burn. Thus, the
aim of this preliminary study was to investigate the effect of an
oral, inexpensive, and accessible collagen-based supplement
on wound healing in patients with burn.
2. Material and methods
2.1. Patients
In this randomized double-blind controlled pilot clinical trial,
34 men were enrolled. To have a power of 90% to detect a 10
difference of change in pre-albumin (also known as trans-
thyretin) between two groups, with a standard deviation (SD)
of 8 and type I error of 5%, a sample size of 14 in each group
seemed to be enough. To compensate for a probable 20% drop
out, 17 patients were recruited to each group. The inclusion
criteria were (1) male, (2) age 1860 years, (3) 2030% total body
surface area (TBSA) burn in body trunk, and (4) ability to oral
intake of food within 2448h of admission. Patients with
prohibition of high protein diets such as those with diabetes,
kidney and liver failure, patients allergic or intolerant to dairy
foods, and those who have consumed high protein or vitamin-
mineral supplements within the past 6 months were not
included. Participants with burn of sole of the foot were not
included due to difficulty of measuring body weight. Besides,
participants with respiratory, gastrointestinal and malabsorp-
tive disorders, immune deficiencies such as HIV infection, and
drug users were not eligible for this study.
Participants were included from those admitted to the
emergency unit of Motahari burns hospital, within 2448h of
admission, considering the inclusion and exclusion criteria.
TBSA was screened using “Rule of Nines” by an emergency
physician and then confirmed by an internist or a surgeon at
admission. Patients were allocated to two groups to receive
either hydrolyzed collagen or placebo supplements. Allocation
was performed through simple randomization and using
computer-generated random numbers, by a hospital staff
blinded to the aim of the study. Patients and main researchers
were blinded to randomization and allocation. Patients in both
groups received standard treatments. The same wound
treatment protocol was used for all patients. Wounds were
washed every day with normal saline and dressings were
changed. A topical bactericidal ointment and vaseline gauze
were used for dressing. Wound excision and grafts were used
to accelerate healing based on the surgeon’s decision. All
participants or their surrogates signed an informed consent
before the initiation of the intervention. The study protocol
was approved by the Ethics Committee of Tehran University of
Medical Sciences. This trial was registered at Iranian Registry
of Clinical Trials (http://www.irct.ir:IRCT2017011015536N5).
2.2. Interventions
The total daily energy need of each patient was calculated by
Curreri formula. Based on available recommendations, the
diet should consist of 2025% protein [7]. It has been decided to
provide 1000kcal of total energy requirement from the
supplements and the rest from usual meals. Daily diet
programs, same in content and source of nutrients between
the two groups, was designed and prescribed by investigators
for each patient individually throughout the study.
In the intervention group, participants received 1000kcal per
day supplement containing 45g gelatin powder (36g hydrolyzed
bovine collagen) (Amutiya, Qom, IRAN) mixed with 100g sugar
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and 500g 3.5% fat yogurt, divided in 4 meals, for 4 weeks. In the
control group, patients received a supplement with the same
calorie. For havinga product withsame physicalcharacteristics,
after heating the mixture of 84g soy flour (35g soy protein), 80g
sugar and 200g water for 10min, it has been mixed with 500g
3.5% fat yogurt and consumed similar to collagen supplement.
All ingredients were weighted by kitchen digital scale. Both
products were prepared by a hospital staff not involved in the
research and packed similarly and coded as A and B. The weight
difference between supplement and control food was about 6g,
which was undetectable by the participants and researchers.
The researchers andhospitalstaffs monitored and documented
the complete intake of main meals and supplements. Supple-
ments and detailed diet programs were given to the patients
who were discharged before the end of 4 weeks, in wound
dressing visits at hospital.
2.3. Assessments
2.3.1. Anthropometries
The patients’ weight were assessed in light clothing at
baseline, end of 2 week, and at the end of the study using a
digital scale (Beurer, Germany). The height was measured
without shoes using a wall-mounted tape (Seca, Germany).
Body mass index (BMI) was calculated as weight (kg) divided by
height square (m2).
2.3.2. Wound area
Changes in wound area were assessed using a visual analogue
scale based on photography at day 1, the end of week 2 and
week 4. Wound healing was defined as the absence of a burn
ulcer and the presence of a new layer of epithelium.
2.3.3. Length of hospital stay
Days of hospital stay were recorded. Some patients did not
need further hospitalization but were instructed to refer to
hospital for regular dressing up to complete wound healing.
2.3.4. Blood sample
At baseline and at the end of week 2 and 4, blood samples were
taken from all participants, and serum stored at 20C. At the
end of the study, serum pre-albumin concentrations were
measured through turbidimetric method (BioSystems SA,
Barcelona, Spain).
2.4. Statistical analysis
MeanSD, mean difference, and confidence interval (CI)
were used to present data. The normal distribution of
variables was assessed using the KolmogorovSmirnov test.
Differences in pre-albumin between collagen and control
groups were analysed using t-test at baseline, end of week 2
and 4. Paired t-test was used to assess within-group changes
(changes in weeks 2 and 4 compared to baseline). To assess
the difference in the rate of wound healing in the two groups
Cox regression and Hazard ratio were used. A P-value less
than 0.05 was considered as statistically significant. SPSS
software (IBM SPSS Statistics for Windows, Version 24.0, IBM
Corp, Armonk, NY, USA) was used to perform the statistical
analysis.
3. Results
Thirty-one participants completed the study. One patient in
the collagen and two patients in the placebo group were
excluded (Fig. 1).
3.1. General characteristics
There were no baseline statistical differences in age (30.19.7
vs. 31.912.4year, P=0.654), BMI (24.74.7 vs. 25.24.9kg/m2,
P=0.778) and other anthropometries, TBSA % (24.74.27 vs.
24.44.54%, P=0.83), and cause of burn (P>0.99), between the
collagen and control groups (Table 1). Depth of burn (Table 2),
and distribution of patients who received wound excision and
grafts were similar in two groups.
3.2. Pre-albumin concentration
Serum pre-albumin levels were significantly higher at the end
of week 2 (29.713.6 vs. 17.87.5mg/dL, P=0.006) and week 4
(35.17.6 vs. 28.38.2mg/dL, P=0.023) in the collagen com-
pared to the control group, respectively. Changes in pre-
albumin concentration from baseline were significantly
higher in the collagen compared to the control group at
week 2 (13.99.8 vs. 1.910.3mg/dL, P<0.001) and week 4
(19.27.5 vs. 8.510.1mg/dL, P=0.002), respectively.
Pre-albumin concentration increased significantly at
week 2 compared to baseline within the collagen group
(P<0.001), but not within the control group (P=0.471). At the
end of week 4, serum pre-albumin was significantly higher
within each of the collagen and control groups compared to
the initiation of the study (P<0.001 and P=0.006, respectively)
(Table 3, Fig. 2)
3.3. Hospital stay
Duration of hospital stay was 9.44.6 days in the collagen and
13.57days in the control group, which was not statistically
significant between the two groups (P=0.063) (Table 2).
3.4. Wound healing
At week 2, wounds were completely healed in 8 (50%) patients
of the collagen and 1 (6.7%) patient of the control groups
(P=0.015). At the end of the study, wounds in all patients of the
collagen and 6 (40%) patients of the control group were entirely
healed (P<0.001) (Table 2). The Hazard ratio of wound healing
was 3.7 times in the collagen compared to the control group
(95% CI: 1.4349.519, P=0.007).
3.5. Anthropometric parameters
There was no significant difference in body weight at the end of
week 2 (74.513.5 vs. 7314kg, P=0.775) and week 4 (7513.9
vs. 72.713.3kg, P=0.639) between the collagen and control
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groups. Changes in body weight from baseline were not
also considerable in the collagen compared to control group
at week 2 (1.54.6 vs. 1.25.9kg, P=0.857) and week 4
(0.94.6 vs. 1.57.5kg, P=0.807), respectively (Fig. 3).
BMI was not significantly different at week 2 (24.24.1
vs. 24.93.8kg/m2, P=0.670) and week 4 (24.44.1 vs.
24.73.4kg/m2, P=0.819) between the intervention and control
groups. In addition, changes in BMI from baseline were not
significantly different between the collagen and control groups
at week 2 (0.51.5 vs. 0.42.1kg/m2, P=0.859) and week 4
(0.31.6 vs. 0.52.5kg/m2, P=0.816), respectively.
No within group changes were observed for body weight or
BMI, neither in the collagen nor in the placebo group, at any
time point.
3.6. Dietary intake
There were no significant differences in dietary intakes of
energy and protein (%) between the collagen and control
groups at baseline and following 4 weeks intervention (Table 4).
Mean energy/kg body weight was 315.6 vs. 30.76.6kcal/kg
at baseline and 39.55.2 vs. 40.45.6kcal/kg at the end of the
study, in the collagen and control groups, respectively. Mean
protein/kg body weight was 1.60.3 vs. 1.60.3g/kg at baseline
and 2.60.4 vs. 2.60.4g/kg at the end of the study, in the
collagen and control groups, respectively. All within group
values (pre- to post-4 weeks intervention) of energy, protein
percentage from energy (%), energy and protein per kg body
weight were increased significantly (P<0.001).
4. Discussion
Pre-albumin concentration and its improvement during
the current study was considerably higher in the collagen
compared to the control group. The wound healing rate
was significantly higher (Hazard ratio: 3.7) following supple-
mentation with a hydrolyzed collagen-based supplement.
Hospital stay was not statistically different between the two
groups, however, this difference seems to be clinically
important. No significant changes were seen in weight and
BMI throughout the study.






Age (years) 31.912.4 30.19.7 0.654*
Weight (kg) 74.217.4 75.915.2 0.764*
Height (cm) 1716 1757 0.115*
BMI (kg/m2) 25.24.9 24.74.7 0.778*
TBSA (%) 24.44.54 24.74.27 0.83**
Cause Petrol 6 (40) 6 (37.5) >0.99***
Gas 4 (26.7) 5 (31.3)
Explosives 2 (13.3) 2 (12.5)
Fire flame 1 (6.7) 2 (12.5)
Other 2 (13.3) 1 (6.3)
Data presented as meanSD or n (%).
* Based on t-test.
** Based on MannWhitney test.
*** Based on Fisher’s exact test.
Fig. 1 – Flow diagram of the study based on CONSORT statement.
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Based on our knowledge, there is no study investigating the
effect of an oral hydrolyzed collagen-based supplement on
wound healing in burn. Low serum pre-albumin levels are
associated with poor nutritional status, longer hospital stay,
delayed wound healing and recovery, and higher mortality
both in chronic diseases and critically ill patients. The
assessment of pre-albumin is recommended due to its short
half-life that reflects rapid responses to both metabolic
stresses and treatments, and also its cost-effectiveness
[15,16]. The current study showed a considerable improve-
ment in pre-albumin concentration following 2 and 4 weeks
consumption of a hydrolyzed collagen-based supplement
compared to the control group in 2030% TBSA burn. Serum
pre-albumin has been considered as a marker of improvement
of nutritional status in patients with 2595% TBSA burn [17].
Pre-albumin concentration was correlated with graft healing,
and is a sensitive and considerable marker determining graft
success in burn [18,19]. There was no clinical report on the
efficacy of oral collagen supplement on pre-albumin levels in
burn. However, it has been shown that comparable
interventions consisting daily 0.5g/kg glutamine for 14 days,
with oral or artificial feeding, could improve circulating pre-
Table 2 – Details of burn characteristics and wound healing in the study population.
Patients Age (year) TBSA (%) Degree Hospital stay (day) Healing at week 2 Healing at week 4
1 26 25 2 & 3 11 No Yes
2 33 30 2 & 3 13 No Yes
3 20 30 2 & 3 8 Yes Yes
4 49 20 2 6 Yes Yes
5 35 30 2 & 3 8 No Yes
6 30 20 2 5 Yes Yes
7 52 20 2 & 3 5 Yes Yes
8 27 20 2 & 3 8 Yes Yes
9 24 25 2 & 3 4 Yes Yes
10 20 20 2 & 3 12 No Yes
11 33 30 2 & 3 15 No Yes
12 20 25 2 & 3 21 No Yes
13 31 20 2 & 3 8 No Yes
14 25 30 2 & 3 10 Yes Yes
15 37 25 2 4 Yes Yes
16 20 25 2 & 3 13 No Yes
17 19 25 2 & 3 32 No No
18 35 29 2 & 3 10 No Yes
19 45 30 2 & 3 10 No No
20 28 30 2 & 3 14 No No
21 33 27 2 6 No No
22 25 20 2 & 3 9 No Yes
23 21 20 2 & 3 21 No No
24 53 20 2 9 No Yes
25 23 30 2 & 3 19 No No
26 50 20 2 & 3 12 No No
27 20 30 2 & 3 19 No No
28 27 20 2 & 3 16 No No
29 20 20 2 6 Yes Yes
30 27 20 2 & 3 7 No Yes
31 53 25 2 & 3 13 No Yes
Table 3 – Pre-albumin concentration (mg/dL) at baseline and following 4 weeks of collagen intervention in patients with burn.
Control (n=15) Collagen (n=16) 95% CI P*
MeanSD MeanSD Diff Lower Upper
Baseline 19.88.8 15.99.5 3.89 10.64 2.86 0.248
Week 2 17.87.5 29.713.6 11.93 3.86 20 0.006
Change week 2 from baseline 1.910.3 13.99.8 15.82 8.44 23.2 <0.001
P** (week 2 vs. baseline) 0.471 <0.001
Week 4 28.38.2 35.17.6 6.78 0.99 12.57 0.023
Change week 4 from baseline 8.510.1 19.27.5 10.67 4.16 17.18 0.002
P** (week 4 vs. baseline) 0.006 <0.001
* Based on t-test.
** Based on paired samples test.
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Fig. 2 – Changes in pre-albumin concentration from baseline to the end of 4 weeks supplementation with collagen in patients
with burn.
Fig. 3 – Changes in weight from baseline to the end of 4 weeks supplementation with collagen in patients with burn.
Table 4 – Dietary intakes at baseline and following 4 weeks of collagen intervention in patients with burn.
Group P*
Control (n=15) Collagen (n=16)
Energy (kcal) Baseline 2199277 2286230 0.349
Week 4 2881287 2911312 0.783
Protein (%) Baseline 21.21.4 21.21.6 0.917
Week 4 25.52.2 25.92.6 0.731
Energy (kcal/kg) Baseline 30.76.6 315.6 0.922
Week 4 40.45.6 39.55.2 0.664
Protein (g/kg) Baseline 1.60.3 1.60.3 0.945
Week 4 2.60.4 2.60.4 0.880
* Based on t-test.
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albumin, accelerate wound healing, and reduce hospital stay
days in 3075% TBSA burn [20].
Oral collagen administration has improved wound healing
in the current trial. Previous studies have shown the efficacy of
collagen-based dressings on wound healing in diabetic foot
ulcer [13], and burn [14]. Collagen dressings were suggested to
modify bacterial burden, support growth factors against
proteases, reduce matrix metalloproteinases, promote cell
proliferation and tissue synthesis, and neutralize free radicals
[21,22]. In addition, 15g hydrolyzed collagen protein, 3 times
daily, for 8 weeks improved pressure ulcer healing in residents
of long-term-care facilities [9]. Experimental studies have also
shown the promising effect of 2g/kg body weight ingestion of
hydrolyzed collagen on wound repair in diabetic ulcers [10].
Potential mechanisms include an increase in capillary density,
vascular endothelial growth factor (VEGF), hydroxyproline and
nitric oxide content of wounds, which all contribute to lower
inflammationand faster tissue repair [12]. Experimental studies
inconditionsother thanwoundhealing havealsoconfirmedthe
efficacy of oral collagen administration on reduction of matrix
metalloproteinase 13, apoptosis, and production of pro-inflam-
matory mediators, interleukin-1, nitric oxide, tumor necrosis
factor, and malondialdehyde [23,24].
Moreover, it has been shown that oral collagen administra-
tion could inhibit UV radiation-induced skin injury (photo-
aging) by increase in the expression of pro-collagen, decrease
matrix metalloproteinase 1, prevent oxidative stress and
inactivation of endogenous antioxidant enzymes like catalase
and glutathione peroxidase, and suppress the expression of
nuclear factor kappa B and its consequent pro-inflammatory
cytokines. Collagen inhibited down-regulation of transforming
growth factor-b1 (TGF-b1) expression and up-regulated the
expression of type II receptor of TGF-b1; the mediators that
control the production of pro-collagen and are involved in the
synthesis of matrix collagen [11,25].
Little is known about the role of soy protein in burns. Soy
protein has good quality and amino acid profile compared to
other plant-based proteins. It has been shown that soy protein
could decrease inflammation, increase transferrin, and improve
wound healing in patients with 2050% TBSA burn [26]. The soy
isoflavone genistein could also accelerate cutaneous wound
healing predominantly through estrogen receptor independent
mechanisms [27]. Genistein has improved diabetic wounds
healing through decreasing oxidative stress, inhibiting inducible
nitric oxide synthase (iNOS) activity and cutaneous forkhead box
O transcription factor 1 (FoxO1) levels [28]. However, the current
studyshowed that this collagen-based supplementcould be even
more effective in improving the outcomes than the control
supplement containing the same amount of soy protein.
Adequate assessment and provision of calorie and protein
needs are of vital importance in patients with burn.
Longitudinal studies have reported that inadequate energy
delivery (<30kcal/kg) was associated with greater weight
loss, and lower pre-albumin concentration [29]. Burn injuries
could be associated with weight loss and prolonged body
composition changes including catabolism of lean body mass
and decrease in total and subcutaneous body fat [30,31].
Modifying these changes could improve immune responses,
rate of wound healing and recovery. In the current study, we
supplied almost total dietary requirements of energy and
protein for each patient in both groups. There was no
considerable weight loss in none of the collagen or control
groups. Both groups received the same amounts of protein
and the source of protein was the only difference between
the two groups, which could be responsible for the observed
differences of pre-albumin concentration, rate of wound
healing and duration of hospital stay.
Length of hospital stay was not statistically different
between collagen (9.5 days) and control (13.5 days) groups;
however, it was clinically considerable. Earlier discharge could
be associated with faster wound healing and better improve-
ment in nutritional status. Lengthy hospitalization could be
associated with more pathophysiological and psychosocial
disorders. Each day of hospitalization also impose high costs to
patients and health systems [32].
Providing adequate metabolic needs of the patients is one of
the strengths of this study, which overcome the challenge of
preventing significant weight loss. However, the major strength
was to formulate and apply a beneficial low-cost oral supple-
ment. This collagen-based supplement could be an excellent
choice both in regular care and in emergencies and disasters.
This study had also some limitations that should be
considered. We did not include women, which could restrict
the generalizability of the findings. The efficacy of this
intervention in women with burn and potential sex differences
in outcomes should be addressed in future studies. In addition,
as a preliminary study, our focus was on practical and clinical
outcomes and clarifying a part of biochemical pathways;
nevertheless, investigating more underlying mechanisms
could strengthen the understanding of the findings, and
should be considered in future studies.
5. Conclusion
The current findings showed that 4 weeks consumption of a
hydrolyzed collagen-based supplement could significantly
improve wound healing rate and serum pre-albumin concen-
tration in men with 2030% burn. The reduction in duration of
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